No Title 1572555806 ⮝
Dear Medical Professional,
Per your order, we have compounded Dextran 75 as a lyophilized powder for injection. The characteristics of this preparation are as follows:
No Title 1572456824 ⮝
Dear Medical Professional,
Per your order, we have compounded Dextran 75 as a lyophilized powder for injection. The characteristics of this preparation are as follows:
Description ⮝
AnazaoHealth supplies compounded Dextran 75 for the preparation of Tc-99m Dextran 75. Each reaction vial contains 10 mg of Dextran 75, 0.30mg of stannous chloride, 0.73 mg Sodium Citrate and 1 mg of dextrose (lyophilized mixture, under nitrogen atmosphere), per unit dose vial.
Mechanism of Action
Dextran, when labeled with technetium Tc99m and given intravenously, is distributed throughout the body in much the same way as the patient s serum, and serves as a suitable tracer with which to transiently image the vascular compartment
Indications And Usage ⮝
Technetium Tc99m Dextran by intravenous administration is indicated as a cardiac blood pool imaging agent and as an adjunct in the diagnosis of pericardial effusion, ventricular aneurysm, or GI Bleed
Dosage And Administration ⮝
To prepare injection, up to 40 mCi of an oxidant-free sodium pertechnetate Tc 99m solution is aseptically injected into the vial, minimum volume 1ml, mix gently and let Dextran dissolve completely for 10 minutes
Storage and Handling
Injection should be administered within 6 hours after preparation. Before and after reconstitution- Store at room temperature
Package Label.principal Display Panel ⮝
Figure 1
DEXTRAN 75
dextran 75 injection, powder, lyophilized, for solution
Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51808-210 Route of Administration INTRAVENOUS
Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DEXTRAN 75 (UNII: JY83SHX053) (DEXTRAN 75 - UNII:JY83SHX053) DEXTRAN 75 10 mg
Inactive Ingredients Ingredient Name Strength STANNOUS CHLORIDE (UNII: 1BQV3749L5) 0.3 mg ANHYDROUS DEXTROSE (UNII: 5SL0G7R0OK) 1 mg SODIUM CITRATE (UNII: 1Q73Q2JULR) 0.73 mg
Product Characteristics Color Score no score Shape Size Flavor Imprint Code Contains
Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:51808-210-01 1 in 1 KIT
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 07/01/2012
Labeler - AnazaoHealth Corporation (011038762)
Establishment Name Address ID/FEI Business Operations AnazaoHealth Corporation 011038762 MANUFACTURE(51808-210) Revised: 7/2012 Document Id: 29c1fd45-7d77-4882-9e73-8a66742be742 Set id: a71129ae-8266-4064-a3f5-6f2897e62981 Version: 1 Effective Time: 20120701 AnazaoHealth Corporation
